Posts Tagged ‘operative’
AcelRx Announces Successful Completion Of End-of-Phase 2 Meeting On ARX-01, Sufentanil NanoTab PCA System For Post-Operative Pain Management
AcelRx Pharmaceuticals, Inc announced that it has successfully completed an End-of-Phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company’s proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route. ARX-01 offers a non-invasive alternative to intravenous patient-controlled analgesia (IV PCA) for the management of acute post-operative pain in the hospital setting.
Newly Published Clinical Data Shows Caldolor(R) (Ibuprofen) Injection Reduces Opioid Use While Improving Pain Relief In Post-Operative Patients
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone.
AcelRx Announces Positive Phase 2 Results From A Study Of ARX-01 Sufentanil NanoTabs In Treating Post-Operative Pain
AcelRx Pharmaceuticals, Inc. announced positive results from the second Phase 2 clinical study evaluating the safety and efficacy of its ARX-01 Sufentanil NanoTabs(TM) for the management of acute post-operative pain in patients requiring opioid analgesia during hospitalization.
AlphaRx And Gaia BioPharma Report Positive Efficacy Results In A Pre-Clinical Trial Of GAI-122 Injectable Nano-emulsion For Post-operative Delirium
AlphaRx Inc. (OTCBB: ALRX) and Gaia BioPharma Limited reported positive pre-clinical results on GAI-122 injectable nanoemulsion in multiple in vitro and in vivo studies of memory impairment after prolonged anesthesia. Delirium is a common mental disorder with serious adverse outcomes in post-operative hospitalized patients.
Managing Acute Post-operative Pain In Hospital
Health professionals caring for patients with acute post-operative pain can improve pain management with a new drug use evaluation toolkit developed by the National Prescribing Service Ltd (NPS). The Acute postoperative pain drug use evaluation (DUE) toolkit can be used by hospitals to assess practices and ensure interventions lead to improvements in a patient’s experience of pain.
Enhanced CNAP Monitor Monitors Peri-operative Fluid Levels Using Non-invasive Pulse Pressure Variation
Following the successful launch of the CNAP Monitor 500i earlier this year, APC Cardiovascular has now launched an enhanced version of the device; which allows anesthetists to measure peri-operative fluid volume using non-invasive pulse pressure variation.
Rx Drug Compare
Translator
By N2H